INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Broad Institute
Cambridge, Estados UnidosPublicacións en colaboración con investigadores/as de Broad Institute (11)
2023
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility
PLoS ONE, Vol. 16, Núm. 8
2018
-
A community approach to mortality prediction in sepsis via gene expression analysis
Nature Communications, Vol. 9, Núm. 1
2017
-
The FASTK family of proteins: Emerging regulators of mitochondrial RNA biology
Nucleic Acids Research, Vol. 45, Núm. 19, pp. 10941-10947
2013
-
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC
Journal of Experimental Medicine, Vol. 210, Núm. 9, pp. 1807-1821